Suspension de la négociation par l'OCRCVM - VAR Canada NewsWire VANCOUVER, BC, le 11 févr. 2022 VANCOUVER, BC, le 11 févr. 2022 /CNW/ - L'OCRCVM a suspendu la négociation des...
IIROC Trading Halt - VAR Canada NewsWire VANCOUVER, BC, Feb. 11, 2022 VANCOUVER, BC, Feb. 11, 2022 /CNW/ - The following issues have been halted by IIROC: Company: VAR Resources Corp. TSX-Venture...
Net earnings per diluted share from continuing operations rise 13 percent to $0.63; revenues rise 6 percent to $541 million; company raises guidance for fiscal year PALO ALTO, Calif., Jan. 27...
Leading Sydney Cancer Hospital to Host Events Teaching Advanced Radiotherapy Techniques to Increase Precision SYDNEY, Jan. 21 /PRNewswire-FirstCall/ -- The Radiation Oncology Department at Royal...
OXFORD, England, Jan. 12 /PRNewswire-FirstCall/ -- A chemotherapy software solution that enables patients to become more involved in managing their own care has been successfully rolled out...
HELSINKI, Dec. 14 /PRNewswire-FirstCall/ -- Cancer patients in Finland have gained access to more advanced treatments with the introduction of RapidArc® radiotherapy technology from Varian...
AMSTERDAM, Nov. 30 /PRNewswire-FirstCall/ -- Researchers from VU University Medical Center in Amsterdam have reported that RapidArc® radiotherapy from Varian Medical Systems (NYSE:VAR) has...
SALT LAKE CITY, Nov. 27 /PRNewswire-FirstCall/ -- Booth - 3646/South Hall A - Varian Medical Systems, Inc. (NYSE:VAR), a premier supplier of X-ray tubes and flat panel digital image detectors...
SALT LAKE CITY, Nov. 18 /PRNewswire-FirstCall/ -- Booth - A78/Hall 10 - Varian Medical Systems, Inc. (NYSE:VAR), a premier supplier of X-ray tubes and flat panel digital image detectors, will...
Noted clinical experts detail recent developments at the annual ASTRO meeting in Chicago PALO ALTO, Calif., Nov. 13 /PRNewswire-FirstCall/ -- Clinical studies suggest that advanced treatments...
Period | Change | Change % | Open | High | Low | Avg. Daily Vol | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | CS |
4 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | CS |
12 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | CS |
26 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | CS |
52 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | CS |
156 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | CS |
260 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | CS |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.